NIIMBL's viral vector program: A cross-gene therapy community collaboration to transform viral vector development and manufacturing

Mol Ther. 2023 Dec 6;31(12):3359-3360. doi: 10.1016/j.ymthe.2023.11.009. Epub 2023 Nov 21.

Authors

Kelvin H Lee¹, Guangping Gao²

Affiliations

¹ National Institute for Innovation in Manufacturing Biopharmaceuticals, University of Delaware, Newark, DE 19713, USA.
² Horae Gene Therapy Center and Viral Vector Core, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA. Electronic address: Guangping.Gao@umassmed.edu.

PMID: 37989318
PMCID: PMC10727964 (available on 2024-12-06)
DOI: 10.1016/j.ymthe.2023.11.009

No abstract available

Publication types

Editorial